HIGH VISCOSITY DERMABOND TOPICAL SKIN ADHESIVE

FDA Premarket Approval P960052 S010

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the addition of propen and propen xl applicators. The device, as modified, will be marketed under the trade names high viscosity dermabond propen topical adhesive and high viscosity dermabond propen xl topical skin adhesive products and are indicated for topical application to hold closed easily approximated skin edges of wounds from surgical incisions, including punctures from minimally invasive surgery, and simple, thoroughly cleansed, trauma-induced lacerations. High viscosity dermabond propen and propen xl may be used in conjunction with, but not in place of subcuticular sutures. Dermabond adhesive may be used in conjunction with, but not in place of deep dermal stitches.

DeviceHIGH VISCOSITY DERMABOND TOPICAL SKIN ADHESIVE
Generic NameTissue Adhesive For The Topical Approximation Of Skin
ApplicantCLOSURE MEDICAL CORP.
Date Received2005-02-09
Decision Date2005-03-21
PMAP960052
SupplementS010
Product CodeMPN 
Advisory CommitteeGeneral & Plastic Surgery
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address CLOSURE MEDICAL CORP. 5265 Capital Blvd. raleigh, NC 27616

Supplemental Filings

Supplement NumberDateSupplement Type
P960052Original Filing
S012 2006-08-16 30-day Notice
S011 2005-12-16 Real-time Process
S010 2005-02-09 Real-time Process
S009 2004-08-19 Normal 180 Day Track No User Fee
S008
S007 2003-10-09 Special (immediate Track)
S006 2003-05-01 Real-time Process
S005 2002-06-27 Special (immediate Track)
S004 2001-05-01 Normal 180 Day Track
S003 2001-04-10 Normal 180 Day Track
S002 2001-03-12 Special (immediate Track)
S001 1999-06-09 Special (immediate Track)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.